Qsemble Capital Management’s Elevance Health ELV Stock Holding History

Qsemble Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	2,934 -7,080	-71%	-$2.63M	0.15%	210
2026 Q1	$2.93M	Buy	+10,014	New	+$3.29M	0.22%	154
2025 Q4	–	Sell	-7,008	Closed	-$2.26M	–	518
2025 Q3	$2.26M	Buy	+7,008	New	+$2.18M	0.22%	145
2025 Q1	–	Sell	-3,693	Closed	-$1.36M	–	475
2024 Q4	$1.36M	Sell	3,693 -6,283	-63%	-$2.63M	0.18%	176
2024 Q3	$5.19M	Buy	+9,976	New	+$5.33M	0.95%	13
2024 Q1	–	Sell	-2,454	Closed	-$1.16M	–	447
2023 Q4	$1.16M	Sell	2,454 -9,471	-79%	-$4.38M	0.29%	122
2023 Q3	$5.19M	Buy	11,925 +8,175	+218%	+$3.71M	0.97%	8
2023 Q2	$1.67M	Buy	+3,750	New	+$1.73M	1.18%	9

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Qsemble Capital Management's ELV Position: Q2 2026 in Review

Qsemble Capital Management reduced its Elevance Health (ELV) stake by 71% in Q2 2026, selling an estimated $2.63M and leaving 2,934 shares worth $1.13M. The position accounts for 0.15% of the portfolio, ranked #210.

Qsemble Capital Management first reported a position in ELV in Q2 2023 and has held it in 8 quarters since. The position peaked at $5.19M in Q3 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Qsemble Capital Management held 2,934 shares of Elevance Health worth $1.13M as of Q2 2026.
Qsemble Capital Management sold 7,080 Elevance Health shares in Q2 2026, an estimated $2.63M.
Elevance Health made up 0.15% of Qsemble Capital Management's portfolio in Q2 2026, its #210 holding.
Qsemble Capital Management first reported a position in Elevance Health in Q2 2023 and has held it in 8 quarters since.
Qsemble Capital Management's Elevance Health position peaked at $5.19M in Q3 2023.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.